| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Troponin I | 21 | 2021 | 662 | 3.450 |
Why?
|
| Troponin | 10 | 2021 | 535 | 2.220 |
Why?
|
| Acute Coronary Syndrome | 25 | 2023 | 2194 | 1.780 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 16 | 2004 | 150 | 1.760 |
Why?
|
| Natriuretic Peptide, Brain | 27 | 2024 | 1751 | 1.740 |
Why?
|
| Heart Failure, Systolic | 3 | 2020 | 134 | 1.650 |
Why?
|
| Potassium | 3 | 2022 | 1315 | 1.520 |
Why?
|
| Troponin T | 12 | 2024 | 787 | 1.480 |
Why?
|
| Heart Failure | 43 | 2024 | 11879 | 1.410 |
Why?
|
| Phlebotomy | 2 | 2022 | 138 | 1.180 |
Why?
|
| Blood Chemical Analysis | 3 | 2018 | 436 | 1.110 |
Why?
|
| Growth Differentiation Factor 15 | 6 | 2024 | 199 | 1.030 |
Why?
|
| Limit of Detection | 9 | 2021 | 277 | 1.010 |
Why?
|
| Immunoassay | 8 | 2021 | 746 | 0.920 |
Why?
|
| Tandem Mass Spectrometry | 8 | 2020 | 1197 | 0.890 |
Why?
|
| Spherocytosis, Hereditary | 9 | 2003 | 83 | 0.860 |
Why?
|
| Peptide Fragments | 20 | 2024 | 5151 | 0.770 |
Why?
|
| Hemolysis | 2 | 2022 | 417 | 0.760 |
Why?
|
| Drug Monitoring | 5 | 2021 | 965 | 0.680 |
Why?
|
| Clinical Chemistry Tests | 3 | 2015 | 59 | 0.620 |
Why?
|
| Exercise Test | 7 | 2020 | 2187 | 0.610 |
Why?
|
| Fibroblast Growth Factors | 4 | 2019 | 873 | 0.610 |
Why?
|
| Blood Group Antigens | 4 | 2004 | 185 | 0.590 |
Why?
|
| Heart Injuries | 2 | 2018 | 207 | 0.580 |
Why?
|
| Atrial Fibrillation | 10 | 2024 | 5176 | 0.570 |
Why?
|
| Chemistry, Clinical | 2 | 2007 | 64 | 0.560 |
Why?
|
| Myocardial Infarction | 19 | 2023 | 11521 | 0.550 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2017 | 171 | 0.550 |
Why?
|
| Laboratories | 4 | 2022 | 463 | 0.540 |
Why?
|
| Erythrocyte Membrane | 12 | 2003 | 438 | 0.530 |
Why?
|
| Spectrin | 10 | 1997 | 176 | 0.530 |
Why?
|
| Troponin C | 1 | 2016 | 48 | 0.530 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 5 | 2019 | 1514 | 0.520 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2020 | 1536 | 0.510 |
Why?
|
| Pathology Department, Hospital | 1 | 2015 | 10 | 0.500 |
Why?
|
| Atherosclerosis | 10 | 2023 | 3431 | 0.500 |
Why?
|
| Kidney Failure, Chronic | 6 | 2019 | 2493 | 0.500 |
Why?
|
| Diabetes Mellitus, Type 2 | 16 | 2023 | 12253 | 0.480 |
Why?
|
| Chromatography, Liquid | 4 | 2014 | 997 | 0.450 |
Why?
|
| Stroke Volume | 18 | 2023 | 5622 | 0.440 |
Why?
|
| Laboratories, Hospital | 1 | 2015 | 192 | 0.440 |
Why?
|
| Urinalysis | 2 | 2013 | 370 | 0.440 |
Why?
|
| Embolism | 3 | 2023 | 401 | 0.440 |
Why?
|
| Utilization Review | 1 | 2015 | 384 | 0.440 |
Why?
|
| Refrigeration | 1 | 2013 | 27 | 0.440 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2013 | 38 | 0.430 |
Why?
|
| Urate Oxidase | 1 | 2013 | 31 | 0.430 |
Why?
|
| Cardiomyopathy, Hypertrophic | 5 | 2024 | 1335 | 0.420 |
Why?
|
| Humans | 186 | 2024 | 768970 | 0.410 |
Why?
|
| Cost Control | 1 | 2015 | 627 | 0.410 |
Why?
|
| Immunoenzyme Techniques | 3 | 2012 | 1705 | 0.410 |
Why?
|
| Elliptocytosis, Hereditary | 6 | 1995 | 29 | 0.400 |
Why?
|
| Performance-Enhancing Substances | 1 | 2012 | 30 | 0.390 |
Why?
|
| Antifungal Agents | 1 | 2017 | 761 | 0.390 |
Why?
|
| Doping in Sports | 1 | 2012 | 62 | 0.390 |
Why?
|
| Calgranulin A | 3 | 2021 | 81 | 0.390 |
Why?
|
| Uracil | 3 | 2018 | 210 | 0.390 |
Why?
|
| Calgranulin B | 3 | 2021 | 87 | 0.390 |
Why?
|
| Ankyrins | 6 | 2003 | 123 | 0.380 |
Why?
|
| Ventricular Dysfunction, Left | 5 | 2023 | 2145 | 0.370 |
Why?
|
| Founder Effect | 3 | 2020 | 185 | 0.370 |
Why?
|
| Prognosis | 33 | 2024 | 30046 | 0.370 |
Why?
|
| Atrial Natriuretic Factor | 5 | 2019 | 350 | 0.360 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2010 | 109 | 0.350 |
Why?
|
| Myocardium | 3 | 2015 | 4790 | 0.350 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2018 | 2297 | 0.340 |
Why?
|
| Middle Aged | 81 | 2024 | 223737 | 0.340 |
Why?
|
| Cardiovascular Diseases | 13 | 2023 | 15661 | 0.330 |
Why?
|
| Glucosides | 3 | 2024 | 533 | 0.330 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2010 | 246 | 0.330 |
Why?
|
| Anabolic Agents | 1 | 2012 | 256 | 0.330 |
Why?
|
| Chest Pain | 5 | 2019 | 1101 | 0.330 |
Why?
|
| Male | 109 | 2024 | 365203 | 0.320 |
Why?
|
| Heart Transplantation | 2 | 2021 | 3301 | 0.310 |
Why?
|
| Thiazoles | 4 | 2021 | 1542 | 0.310 |
Why?
|
| Mutation | 19 | 2020 | 30266 | 0.310 |
Why?
|
| Sarcomeres | 3 | 2024 | 380 | 0.300 |
Why?
|
| Kidney Transplantation | 4 | 2018 | 4265 | 0.300 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 1292 | 0.300 |
Why?
|
| Female | 110 | 2024 | 397515 | 0.300 |
Why?
|
| Autoanalysis | 1 | 2007 | 70 | 0.290 |
Why?
|
| Cost Savings | 1 | 2013 | 915 | 0.290 |
Why?
|
| Tachycardia, Ventricular | 2 | 2016 | 1309 | 0.280 |
Why?
|
| Sensitivity and Specificity | 15 | 2021 | 14752 | 0.280 |
Why?
|
| Uric Acid | 1 | 2013 | 806 | 0.280 |
Why?
|
| Proteomics | 4 | 2024 | 3914 | 0.270 |
Why?
|
| Acetanilides | 3 | 2014 | 169 | 0.270 |
Why?
|
| Aged | 62 | 2024 | 171786 | 0.270 |
Why?
|
| Aortic Diseases | 3 | 2018 | 741 | 0.260 |
Why?
|
| Reticulocytes | 7 | 1998 | 288 | 0.260 |
Why?
|
| Hemorrhage | 5 | 2023 | 3466 | 0.260 |
Why?
|
| Blood Glucose | 4 | 2017 | 6435 | 0.260 |
Why?
|
| Antibodies, Viral | 5 | 2024 | 3215 | 0.250 |
Why?
|
| Glucuronidase | 2 | 2019 | 205 | 0.250 |
Why?
|
| Erythrocytes | 9 | 2003 | 2421 | 0.240 |
Why?
|
| Ventricular Function, Left | 8 | 2023 | 3941 | 0.240 |
Why?
|
| Piperidines | 4 | 2018 | 1667 | 0.240 |
Why?
|
| HIV Seropositivity | 1 | 2010 | 967 | 0.240 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 2227 | 0.240 |
Why?
|
| Biological Assay | 3 | 2017 | 628 | 0.230 |
Why?
|
| AIDS Vaccines | 1 | 2010 | 900 | 0.230 |
Why?
|
| Adamantane | 2 | 2015 | 148 | 0.220 |
Why?
|
| Medication Adherence | 2 | 2013 | 2192 | 0.220 |
Why?
|
| Risk Assessment | 18 | 2024 | 24333 | 0.220 |
Why?
|
| Point Mutation | 4 | 1997 | 1596 | 0.220 |
Why?
|
| Multiple Myeloma | 3 | 2021 | 5196 | 0.220 |
Why?
|
| Benzhydryl Compounds | 4 | 2024 | 944 | 0.220 |
Why?
|
| Pyridines | 4 | 2021 | 2895 | 0.220 |
Why?
|
| Nijmegen Breakage Syndrome | 2 | 2016 | 4 | 0.220 |
Why?
|
| HIV Antibodies | 1 | 2010 | 1341 | 0.220 |
Why?
|
| Ventricular Remodeling | 3 | 2024 | 1282 | 0.210 |
Why?
|
| Antibodies, Monoclonal | 3 | 2017 | 9264 | 0.210 |
Why?
|
| Anticholesteremic Agents | 2 | 2021 | 972 | 0.210 |
Why?
|
| Dipeptides | 2 | 2015 | 386 | 0.210 |
Why?
|
| P-Selectin | 2 | 2021 | 599 | 0.210 |
Why?
|
| Stroke | 7 | 2023 | 9756 | 0.210 |
Why?
|
| Acidosis, Renal Tubular | 2 | 2004 | 50 | 0.200 |
Why?
|
| Catheter Ablation | 1 | 2016 | 2780 | 0.200 |
Why?
|
| Adiponectin | 2 | 2019 | 1117 | 0.200 |
Why?
|
| Obstetric Labor, Premature | 1 | 2004 | 268 | 0.200 |
Why?
|
| Kidney Function Tests | 3 | 2017 | 684 | 0.200 |
Why?
|
| Exercise Tolerance | 4 | 2020 | 846 | 0.190 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2007 | 749 | 0.190 |
Why?
|
| Alleles | 8 | 2019 | 6901 | 0.190 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 8 | 2020 | 3253 | 0.190 |
Why?
|
| Predictive Value of Tests | 12 | 2021 | 15471 | 0.190 |
Why?
|
| Endothelium, Vascular | 3 | 2015 | 4428 | 0.190 |
Why?
|
| Testosterone | 1 | 2012 | 2493 | 0.190 |
Why?
|
| Coronary Disease | 4 | 2011 | 5919 | 0.190 |
Why?
|
| Hematologic Tests | 1 | 2022 | 239 | 0.190 |
Why?
|
| Erythrocytes, Abnormal | 3 | 2002 | 121 | 0.190 |
Why?
|
| Insulin | 2 | 2014 | 6610 | 0.180 |
Why?
|
| Genes, Dominant | 4 | 2004 | 856 | 0.180 |
Why?
|
| Glomerular Filtration Rate | 5 | 2018 | 2228 | 0.180 |
Why?
|
| Neoplasms, Plasma Cell | 1 | 2021 | 39 | 0.180 |
Why?
|
| Antigens, Surface | 2 | 2011 | 1616 | 0.180 |
Why?
|
| Buprenorphine | 3 | 2014 | 667 | 0.180 |
Why?
|
| Blood Proteins | 4 | 2016 | 1191 | 0.180 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2016 | 507 | 0.180 |
Why?
|
| Receptors, LDL | 4 | 2016 | 492 | 0.180 |
Why?
|
| Heart Diseases | 1 | 2014 | 2819 | 0.180 |
Why?
|
| Cholesterol | 2 | 2020 | 2913 | 0.180 |
Why?
|
| Glycopeptides | 4 | 2016 | 225 | 0.180 |
Why?
|
| Double-Blind Method | 11 | 2019 | 12467 | 0.180 |
Why?
|
| Lymphocyte Activation | 7 | 2019 | 5505 | 0.170 |
Why?
|
| Fibronectins | 1 | 2004 | 724 | 0.170 |
Why?
|
| Arginine | 2 | 1995 | 932 | 0.170 |
Why?
|
| Hospitalization | 10 | 2021 | 10847 | 0.170 |
Why?
|
| Antiporters | 2 | 1998 | 276 | 0.170 |
Why?
|
| Antibodies | 2 | 2019 | 2422 | 0.170 |
Why?
|
| Metformin | 4 | 2022 | 909 | 0.170 |
Why?
|
| Immunoglobulin M | 2 | 2021 | 1528 | 0.160 |
Why?
|
| Peptide Library | 1 | 2001 | 351 | 0.160 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2021 | 619 | 0.160 |
Why?
|
| Reproducibility of Results | 8 | 2021 | 20245 | 0.160 |
Why?
|
| Chronic Disease | 7 | 2020 | 9384 | 0.160 |
Why?
|
| Diuretics, Osmotic | 1 | 2019 | 33 | 0.160 |
Why?
|
| Heterozygote | 5 | 2020 | 2798 | 0.160 |
Why?
|
| Molecular Sequence Data | 13 | 2006 | 17629 | 0.160 |
Why?
|
| Systole | 2 | 2018 | 937 | 0.160 |
Why?
|
| Sodium | 3 | 2020 | 1597 | 0.160 |
Why?
|
| Spironolactone | 2 | 2020 | 415 | 0.160 |
Why?
|
| Interleukin-1 | 1 | 2003 | 1251 | 0.160 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 2 | 2021 | 306 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 11 | 2003 | 6086 | 0.160 |
Why?
|
| Natriuretic Peptides | 1 | 2020 | 156 | 0.160 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 5 | 2003 | 326 | 0.160 |
Why?
|
| DNA, Complementary | 7 | 2003 | 1990 | 0.160 |
Why?
|
| Shock, Cardiogenic | 1 | 2024 | 711 | 0.160 |
Why?
|
| Membrane Proteins | 6 | 2021 | 7885 | 0.160 |
Why?
|
| Mannitol | 1 | 2019 | 177 | 0.160 |
Why?
|
| Fentanyl | 2 | 2013 | 450 | 0.150 |
Why?
|
| C-Reactive Protein | 7 | 2019 | 3859 | 0.150 |
Why?
|
| Risk Factors | 25 | 2023 | 74976 | 0.150 |
Why?
|
| Patient Compliance | 1 | 2009 | 2701 | 0.150 |
Why?
|
| Exercise | 5 | 2020 | 5954 | 0.150 |
Why?
|
| Coronary Restenosis | 1 | 2021 | 396 | 0.150 |
Why?
|
| Amino Acid Substitution | 2 | 2019 | 1742 | 0.150 |
Why?
|
| Vitamin D | 1 | 2012 | 3311 | 0.150 |
Why?
|
| Cloning, Molecular | 3 | 2001 | 4168 | 0.150 |
Why?
|
| Isoantigens | 2 | 1997 | 562 | 0.150 |
Why?
|
| Symporters | 1 | 2020 | 363 | 0.150 |
Why?
|
| Immunoglobulins, Thyroid-Stimulating | 1 | 2017 | 34 | 0.150 |
Why?
|
| Immunoelectrophoresis | 1 | 2017 | 94 | 0.150 |
Why?
|
| Analgesics, Opioid | 3 | 2014 | 3838 | 0.150 |
Why?
|
| Substance Abuse Detection | 2 | 2012 | 301 | 0.150 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2023 | 644 | 0.140 |
Why?
|
| RNA, Messenger | 9 | 2004 | 12806 | 0.140 |
Why?
|
| Plaque, Atherosclerotic | 4 | 2018 | 1550 | 0.140 |
Why?
|
| Collagen Type I | 2 | 2019 | 620 | 0.140 |
Why?
|
| Luminescent Measurements | 2 | 2010 | 342 | 0.140 |
Why?
|
| Piperazines | 3 | 2014 | 2553 | 0.140 |
Why?
|
| Thyroglobulin | 1 | 2017 | 111 | 0.140 |
Why?
|
| Adult | 37 | 2024 | 223851 | 0.140 |
Why?
|
| Itraconazole | 1 | 2017 | 43 | 0.140 |
Why?
|
| Coronary Artery Bypass | 3 | 2014 | 2194 | 0.140 |
Why?
|
| Electrocardiography | 5 | 2017 | 6413 | 0.140 |
Why?
|
| Secondary Prevention | 2 | 2021 | 1476 | 0.140 |
Why?
|
| Base Sequence | 12 | 1996 | 12430 | 0.140 |
Why?
|
| Diuretics | 1 | 2020 | 614 | 0.140 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 243 | 0.140 |
Why?
|
| Graft Rejection | 3 | 2021 | 4492 | 0.140 |
Why?
|
| Reference Values | 5 | 2017 | 4940 | 0.130 |
Why?
|
| Fluconazole | 1 | 2017 | 156 | 0.130 |
Why?
|
| Patient Admission | 1 | 2004 | 1370 | 0.130 |
Why?
|
| Proportional Hazards Models | 7 | 2021 | 12562 | 0.130 |
Why?
|
| Glycoproteins | 1 | 2004 | 2202 | 0.130 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 2 | 2016 | 60 | 0.130 |
Why?
|
| Substance-Related Disorders | 2 | 2012 | 4423 | 0.130 |
Why?
|
| Insulin Resistance | 3 | 2022 | 3982 | 0.130 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2015 | 25 | 0.130 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2017 | 91 | 0.130 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 2 | 2017 | 317 | 0.120 |
Why?
|
| Genetic Variation | 1 | 2010 | 6611 | 0.120 |
Why?
|
| DNA, Satellite | 1 | 1995 | 67 | 0.120 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2019 | 582 | 0.120 |
Why?
|
| Myocardial Ischemia | 4 | 2019 | 2139 | 0.120 |
Why?
|
| Treatment Outcome | 14 | 2023 | 65480 | 0.120 |
Why?
|
| Survival Analysis | 5 | 2018 | 10115 | 0.120 |
Why?
|
| Thromboembolism | 1 | 2021 | 1004 | 0.120 |
Why?
|
| Prospective Studies | 20 | 2021 | 54962 | 0.120 |
Why?
|
| Endothelin-1 | 4 | 2023 | 296 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2019 | 6547 | 0.120 |
Why?
|
| Minisatellite Repeats | 1 | 1995 | 164 | 0.120 |
Why?
|
| Cell Cycle Proteins | 3 | 2016 | 3450 | 0.110 |
Why?
|
| Renin-Angiotensin System | 1 | 2019 | 736 | 0.110 |
Why?
|
| Heart Rate | 3 | 2016 | 4217 | 0.110 |
Why?
|
| Galectin 3 | 2 | 2016 | 240 | 0.110 |
Why?
|
| Protein Array Analysis | 1 | 2015 | 400 | 0.110 |
Why?
|
| Anticoagulants | 4 | 2024 | 4850 | 0.110 |
Why?
|
| Time Factors | 10 | 2019 | 40261 | 0.110 |
Why?
|
| Interleukin-18 | 1 | 2015 | 251 | 0.110 |
Why?
|
| Amino Acid Sequence | 7 | 2006 | 13427 | 0.110 |
Why?
|
| Pain | 1 | 2009 | 5100 | 0.110 |
Why?
|
| Case-Control Studies | 8 | 2024 | 22296 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 2018 | 521 | 0.110 |
Why?
|
| Morphine Derivatives | 1 | 2013 | 43 | 0.110 |
Why?
|
| Methotrexate | 1 | 2020 | 1723 | 0.110 |
Why?
|
| Antihypertensive Agents | 2 | 2020 | 2027 | 0.110 |
Why?
|
| Shear Strength | 1 | 2013 | 160 | 0.110 |
Why?
|
| Diabetic Angiopathies | 1 | 2018 | 806 | 0.110 |
Why?
|
| Hypotension | 1 | 2019 | 888 | 0.100 |
Why?
|
| HIV-1 | 1 | 2010 | 6962 | 0.100 |
Why?
|
| Chemokine CCL2 | 2 | 2007 | 606 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2011 | 4356 | 0.100 |
Why?
|
| Randomized Controlled Trials as Topic | 7 | 2021 | 10400 | 0.100 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2014 | 153 | 0.100 |
Why?
|
| Lymphocytes | 2 | 2023 | 2614 | 0.100 |
Why?
|
| Enzyme Inhibitors | 3 | 2014 | 3726 | 0.100 |
Why?
|
| Chromosome Deletion | 2 | 2021 | 1390 | 0.100 |
Why?
|
| Tramadol | 1 | 2013 | 63 | 0.100 |
Why?
|
| Immunoglobulin G | 2 | 2021 | 4568 | 0.100 |
Why?
|
| Standard of Care | 1 | 2017 | 569 | 0.100 |
Why?
|
| E-Selectin | 2 | 2006 | 578 | 0.100 |
Why?
|
| Thrombosis | 2 | 2021 | 2956 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5716 | 0.100 |
Why?
|
| Indoles | 3 | 2019 | 1836 | 0.100 |
Why?
|
| Reproduction | 1 | 2016 | 646 | 0.100 |
Why?
|
| Registries | 4 | 2024 | 8384 | 0.100 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2018 | 1064 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2017 | 2932 | 0.100 |
Why?
|
| Interleukin-6 | 2 | 2017 | 3232 | 0.100 |
Why?
|
| Anemia | 2 | 2011 | 1517 | 0.100 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 294 | 0.100 |
Why?
|
| Triazoles | 1 | 2017 | 904 | 0.100 |
Why?
|
| Echocardiography, Doppler | 1 | 2015 | 898 | 0.090 |
Why?
|
| Pedigree | 8 | 2020 | 4545 | 0.090 |
Why?
|
| Th17 Cells | 1 | 2018 | 791 | 0.090 |
Why?
|
| Anemia, Hemolytic | 1 | 1992 | 164 | 0.090 |
Why?
|
| Methemoglobin | 1 | 1990 | 25 | 0.090 |
Why?
|
| Haplotypes | 3 | 2016 | 2725 | 0.090 |
Why?
|
| Nuclear Proteins | 3 | 2016 | 5804 | 0.090 |
Why?
|
| Cohort Studies | 11 | 2019 | 41808 | 0.090 |
Why?
|
| Vasodilation | 1 | 2015 | 967 | 0.090 |
Why?
|
| Follow-Up Studies | 9 | 2021 | 39394 | 0.090 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 1437 | 0.090 |
Why?
|
| Hemeproteins | 1 | 1990 | 61 | 0.090 |
Why?
|
| Proline | 1 | 1992 | 455 | 0.090 |
Why?
|
| Peptides | 3 | 2019 | 4353 | 0.090 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2012 | 394 | 0.090 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2014 | 1899 | 0.090 |
Why?
|
| Kidney Diseases | 2 | 2011 | 2100 | 0.090 |
Why?
|
| Salvage Therapy | 1 | 2017 | 1277 | 0.090 |
Why?
|
| Polymorphism, Genetic | 6 | 2007 | 4251 | 0.090 |
Why?
|
| CD40 Ligand | 2 | 2021 | 528 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2020 | 2241 | 0.090 |
Why?
|
| Myeloablative Agonists | 1 | 2010 | 210 | 0.090 |
Why?
|
| Decision Making | 1 | 2004 | 3953 | 0.090 |
Why?
|
| Narcotics | 1 | 2012 | 332 | 0.080 |
Why?
|
| Procollagen | 1 | 2010 | 189 | 0.080 |
Why?
|
| Frameshift Mutation | 3 | 2003 | 393 | 0.080 |
Why?
|
| Thrombolytic Therapy | 2 | 2021 | 2055 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2848 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2021 | 3116 | 0.080 |
Why?
|
| B-Lymphocytes | 2 | 2021 | 4794 | 0.080 |
Why?
|
| Sex Factors | 3 | 2018 | 10633 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2021 | 9549 | 0.080 |
Why?
|
| Renal Dialysis | 1 | 2019 | 1789 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 13594 | 0.080 |
Why?
|
| Serine Endopeptidases | 1 | 2014 | 1027 | 0.080 |
Why?
|
| Hypercholesterolemia | 2 | 2013 | 1145 | 0.080 |
Why?
|
| Absorptiometry, Photon | 1 | 2015 | 1758 | 0.080 |
Why?
|
| Dendritic Cells | 2 | 2019 | 2748 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 2414 | 0.080 |
Why?
|
| Mortality | 2 | 2017 | 2914 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1890 | 0.080 |
Why?
|
| Multivariate Analysis | 4 | 2015 | 12095 | 0.080 |
Why?
|
| Interleukin-2 | 1 | 2015 | 1895 | 0.080 |
Why?
|
| Emergency Service, Hospital | 3 | 2019 | 7957 | 0.080 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 1601 | 0.080 |
Why?
|
| Myocarditis | 2 | 2006 | 803 | 0.080 |
Why?
|
| Echocardiography | 5 | 2021 | 5047 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 2 | 1992 | 1328 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 2020 | 4939 | 0.080 |
Why?
|
| T-Lymphocytes | 3 | 2019 | 10276 | 0.080 |
Why?
|
| Hemoglobins | 2 | 1994 | 1531 | 0.080 |
Why?
|
| Specimen Handling | 1 | 2013 | 708 | 0.080 |
Why?
|
| Chromosome Disorders | 2 | 2021 | 499 | 0.080 |
Why?
|
| False Positive Reactions | 1 | 2010 | 963 | 0.070 |
Why?
|
| Benzaldehydes | 2 | 2018 | 59 | 0.070 |
Why?
|
| Disease Progression | 5 | 2019 | 13674 | 0.070 |
Why?
|
| Mice, Knockout | 7 | 2019 | 14484 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2019 | 1989 | 0.070 |
Why?
|
| Disease Models, Animal | 8 | 2019 | 18354 | 0.070 |
Why?
|
| Phenotype | 9 | 2020 | 16731 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2010 | 5033 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2017 | 4148 | 0.070 |
Why?
|
| Introns | 3 | 1996 | 969 | 0.070 |
Why?
|
| Gene Expression | 4 | 2019 | 7603 | 0.070 |
Why?
|
| Ventricular Dysfunction | 1 | 2008 | 144 | 0.070 |
Why?
|
| Aged, 80 and over | 12 | 2021 | 59739 | 0.070 |
Why?
|
| Risk | 6 | 2019 | 9621 | 0.070 |
Why?
|
| Codon | 3 | 1995 | 599 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 8 | 2021 | 22379 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 8055 | 0.070 |
Why?
|
| Plasma Cells | 2 | 2021 | 599 | 0.070 |
Why?
|
| Urotensins | 1 | 2006 | 7 | 0.070 |
Why?
|
| Cell Migration Inhibition | 1 | 2006 | 97 | 0.070 |
Why?
|
| Sulfates | 2 | 1998 | 379 | 0.070 |
Why?
|
| Mannose-Binding Lectin | 1 | 2007 | 146 | 0.070 |
Why?
|
| Oximes | 2 | 2018 | 303 | 0.070 |
Why?
|
| Cytoskeleton | 2 | 1990 | 1179 | 0.070 |
Why?
|
| Cell Proliferation | 4 | 2016 | 10486 | 0.070 |
Why?
|
| Antibody Formation | 2 | 2021 | 1393 | 0.070 |
Why?
|
| Blood Component Removal | 1 | 2007 | 132 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2016 | 2990 | 0.070 |
Why?
|
| Androgen Antagonists | 1 | 2015 | 1421 | 0.070 |
Why?
|
| Endothelins | 1 | 2006 | 127 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2020 | 18068 | 0.060 |
Why?
|
| Mice | 13 | 2021 | 82072 | 0.060 |
Why?
|
| Carcinoma | 1 | 2017 | 2340 | 0.060 |
Why?
|
| Receptors, Chemokine | 2 | 2006 | 652 | 0.060 |
Why?
|
| Immunity, Innate | 2 | 2015 | 3080 | 0.060 |
Why?
|
| Blood Gas Analysis | 1 | 2007 | 384 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 1966 | 0.060 |
Why?
|
| Macrophages | 3 | 2016 | 5801 | 0.060 |
Why?
|
| Pravastatin | 3 | 2016 | 393 | 0.060 |
Why?
|
| Animals | 20 | 2021 | 169335 | 0.060 |
Why?
|
| Coculture Techniques | 2 | 2016 | 1342 | 0.060 |
Why?
|
| Hemodynamics | 3 | 2021 | 4199 | 0.060 |
Why?
|
| Protein Precursors | 3 | 2016 | 1135 | 0.060 |
Why?
|
| Glucose | 2 | 2020 | 4352 | 0.060 |
Why?
|
| Postoperative Complications | 4 | 2017 | 15889 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 1151 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2016 | 4413 | 0.060 |
Why?
|
| Warfarin | 2 | 2023 | 1493 | 0.060 |
Why?
|
| Exons | 4 | 1996 | 2395 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2019 | 5906 | 0.060 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 2057 | 0.060 |
Why?
|
| Cardiac Output, Low | 1 | 2006 | 192 | 0.060 |
Why?
|
| Receptors, Cell Surface | 2 | 2007 | 2820 | 0.060 |
Why?
|
| Artifacts | 1 | 2014 | 1942 | 0.060 |
Why?
|
| Chemokine CCL5 | 2 | 2003 | 214 | 0.060 |
Why?
|
| Acute Disease | 4 | 2014 | 7245 | 0.060 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8559 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2012 | 1495 | 0.060 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2021 | 276 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2021 | 3811 | 0.060 |
Why?
|
| Infant, Newborn | 3 | 2022 | 26428 | 0.060 |
Why?
|
| Heart Ventricles | 1 | 2017 | 3840 | 0.060 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2006 | 239 | 0.060 |
Why?
|
| Cell Movement | 2 | 2006 | 5216 | 0.060 |
Why?
|
| Diabetic Nephropathies | 1 | 2011 | 973 | 0.060 |
Why?
|
| RNA | 4 | 1997 | 2727 | 0.060 |
Why?
|
| Pulmonary Edema | 1 | 2007 | 409 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2018 | 8544 | 0.060 |
Why?
|
| Adrenomedullin | 2 | 2016 | 85 | 0.060 |
Why?
|
| Cells, Cultured | 6 | 2016 | 19023 | 0.060 |
Why?
|
| T-Box Domain Proteins | 1 | 2006 | 472 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2017 | 2360 | 0.060 |
Why?
|
| Coronary Artery Disease | 3 | 2018 | 6569 | 0.060 |
Why?
|
| Transplantation Conditioning | 1 | 2010 | 1601 | 0.060 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2011 | 1803 | 0.060 |
Why?
|
| DNA | 5 | 1997 | 7214 | 0.050 |
Why?
|
| Conserved Sequence | 2 | 1998 | 1162 | 0.050 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 1997 | 394 | 0.050 |
Why?
|
| Asia, Southeastern | 3 | 1994 | 115 | 0.050 |
Why?
|
| Slovakia | 2 | 2016 | 9 | 0.050 |
Why?
|
| Chemokine CXCL6 | 1 | 2003 | 14 | 0.050 |
Why?
|
| Czech Republic | 2 | 2016 | 75 | 0.050 |
Why?
|
| DNA Mutational Analysis | 4 | 2007 | 4124 | 0.050 |
Why?
|
| Dominican Republic | 1 | 2023 | 78 | 0.050 |
Why?
|
| DNA Primers | 4 | 1995 | 2827 | 0.050 |
Why?
|
| Chromans | 1 | 2003 | 116 | 0.050 |
Why?
|
| Amitriptyline | 1 | 2003 | 112 | 0.050 |
Why?
|
| International Normalized Ratio | 1 | 2005 | 382 | 0.050 |
Why?
|
| Drug Prescriptions | 2 | 2011 | 1673 | 0.050 |
Why?
|
| Pilot Projects | 5 | 2019 | 8748 | 0.050 |
Why?
|
| Coronary Care Units | 1 | 2024 | 235 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2011 | 1813 | 0.050 |
Why?
|
| Quality of Life | 2 | 2022 | 13510 | 0.050 |
Why?
|
| Kinetics | 3 | 2022 | 6332 | 0.050 |
Why?
|
| Hemoglobin, Sickle | 1 | 2003 | 113 | 0.050 |
Why?
|
| Hypoglycemic Agents | 3 | 2017 | 3110 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1994 | 1057 | 0.050 |
Why?
|
| Nucleocapsid | 1 | 2022 | 62 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 3 | 1998 | 4785 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2007 | 999 | 0.050 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 26395 | 0.050 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2002 | 43 | 0.050 |
Why?
|
| Blood Protein Electrophoresis | 2 | 1992 | 65 | 0.050 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2007 | 407 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2010 | 2871 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2015 | 3628 | 0.050 |
Why?
|
| Codon, Nonsense | 1 | 2003 | 287 | 0.050 |
Why?
|
| Palliative Care | 1 | 2017 | 3644 | 0.050 |
Why?
|
| Malaria | 1 | 1991 | 1249 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 15951 | 0.050 |
Why?
|
| Phosphatidylserines | 1 | 2003 | 186 | 0.050 |
Why?
|
| Age of Onset | 2 | 2020 | 3346 | 0.050 |
Why?
|
| Genotype | 3 | 2011 | 13048 | 0.050 |
Why?
|
| Sequence Deletion | 2 | 1996 | 1498 | 0.050 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2003 | 430 | 0.050 |
Why?
|
| Retrospective Studies | 8 | 2020 | 81903 | 0.050 |
Why?
|
| Chemokines, CXC | 1 | 2003 | 420 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 1989 | 1163 | 0.050 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 11932 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2022 | 405 | 0.050 |
Why?
|
| Young Adult | 6 | 2024 | 60131 | 0.040 |
Why?
|
| Survival Rate | 4 | 2018 | 12873 | 0.040 |
Why?
|
| Thyroxine | 1 | 2004 | 665 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2021 | 192 | 0.040 |
Why?
|
| Alternative Splicing | 2 | 1996 | 1105 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2012 | 1947 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1992 | 706 | 0.040 |
Why?
|
| STAT5 Transcription Factor | 1 | 2021 | 268 | 0.040 |
Why?
|
| Plasmacytoma | 1 | 2021 | 170 | 0.040 |
Why?
|
| Peroxidase | 2 | 2016 | 610 | 0.040 |
Why?
|
| Lipoproteins, LDL | 2 | 2016 | 643 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2003 | 692 | 0.040 |
Why?
|
| Microsatellite Repeats | 2 | 2003 | 785 | 0.040 |
Why?
|
| Thiazolidinediones | 1 | 2003 | 461 | 0.040 |
Why?
|
| Iceland | 1 | 2020 | 183 | 0.040 |
Why?
|
| Oxygen Consumption | 2 | 2019 | 1883 | 0.040 |
Why?
|
| Algorithms | 1 | 2020 | 14201 | 0.040 |
Why?
|
| Bupivacaine | 1 | 2003 | 414 | 0.040 |
Why?
|
| Heredity | 1 | 2020 | 149 | 0.040 |
Why?
|
| ROC Curve | 3 | 2014 | 3629 | 0.040 |
Why?
|
| Hypertonic Solutions | 1 | 2019 | 82 | 0.040 |
Why?
|
| Hypothyroidism | 1 | 2004 | 667 | 0.040 |
Why?
|
| Agglutination | 1 | 1998 | 42 | 0.040 |
Why?
|
| Platelet Function Tests | 1 | 2021 | 275 | 0.040 |
Why?
|
| Carbon Isotopes | 1 | 2020 | 458 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2007 | 1887 | 0.040 |
Why?
|
| Mice, Transgenic | 4 | 2019 | 9565 | 0.040 |
Why?
|
| Inflammation | 3 | 2021 | 10868 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2003 | 1133 | 0.040 |
Why?
|
| Hematologic Neoplasms | 1 | 2010 | 1907 | 0.040 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2018 | 24 | 0.040 |
Why?
|
| Isotope Labeling | 1 | 2020 | 395 | 0.040 |
Why?
|
| B-Cell Maturation Antigen | 1 | 2019 | 149 | 0.040 |
Why?
|
| Graft Survival | 2 | 2021 | 3888 | 0.040 |
Why?
|
| Respiratory Insufficiency | 1 | 2007 | 1241 | 0.040 |
Why?
|
| Penetrance | 1 | 2020 | 386 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2021 | 2674 | 0.040 |
Why?
|
| Recurrence | 3 | 2018 | 8513 | 0.040 |
Why?
|
| Kidney | 3 | 2020 | 7058 | 0.040 |
Why?
|
| Chloride-Bicarbonate Antiporters | 1 | 1998 | 103 | 0.040 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2019 | 325 | 0.040 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2019 | 162 | 0.040 |
Why?
|
| Multigene Family | 1 | 2021 | 1082 | 0.040 |
Why?
|
| Aorta | 2 | 2015 | 2046 | 0.040 |
Why?
|
| Chymotrypsin | 1 | 1997 | 137 | 0.040 |
Why?
|
| Calibration | 1 | 2020 | 822 | 0.040 |
Why?
|
| Hormones | 1 | 2021 | 870 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2019 | 6320 | 0.040 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1996 | 30 | 0.040 |
Why?
|
| Isoleucine | 1 | 1997 | 112 | 0.040 |
Why?
|
| Heptanoic Acids | 2 | 2011 | 344 | 0.040 |
Why?
|
| Bicarbonates | 1 | 1998 | 292 | 0.030 |
Why?
|
| Cytokines | 3 | 2016 | 7453 | 0.030 |
Why?
|
| Simvastatin | 1 | 2019 | 346 | 0.030 |
Why?
|
| Academic Medical Centers | 2 | 2017 | 2784 | 0.030 |
Why?
|
| Polysomnography | 2 | 2014 | 1871 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2011 | 4651 | 0.030 |
Why?
|
| Intensive Care Units | 2 | 2007 | 3800 | 0.030 |
Why?
|
| Rhabdomyolysis | 1 | 2018 | 150 | 0.030 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1996 | 167 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2007 | 4032 | 0.030 |
Why?
|
| Germany | 1 | 2019 | 883 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1998 | 419 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2013 | 2360 | 0.030 |
Why?
|
| Threonine | 1 | 1997 | 273 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 2003 | 1005 | 0.030 |
Why?
|
| Genetic Markers | 2 | 2004 | 2604 | 0.030 |
Why?
|
| Transplantation Tolerance | 1 | 2021 | 633 | 0.030 |
Why?
|
| beta 2-Microglobulin | 1 | 2017 | 330 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 2 | 2016 | 2709 | 0.030 |
Why?
|
| Telomerase | 1 | 2001 | 753 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2005 | 1240 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 1998 | 610 | 0.030 |
Why?
|
| Microscopy, Electron | 3 | 1994 | 2560 | 0.030 |
Why?
|
| Cystatin C | 1 | 2017 | 272 | 0.030 |
Why?
|
| Cholesterol, VLDL | 1 | 2015 | 70 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4592 | 0.030 |
Why?
|
| Life Style | 2 | 2020 | 3931 | 0.030 |
Why?
|
| Osmotic Fragility | 1 | 1995 | 35 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2019 | 2298 | 0.030 |
Why?
|
| Morbidity | 1 | 2021 | 1757 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 5892 | 0.030 |
Why?
|
| Fever | 1 | 2023 | 1619 | 0.030 |
Why?
|
| Thoracic Injuries | 1 | 2018 | 288 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 11116 | 0.030 |
Why?
|
| Apolipoprotein B-100 | 1 | 2015 | 157 | 0.030 |
Why?
|
| Chlorides | 1 | 1998 | 666 | 0.030 |
Why?
|
| Telomere | 1 | 2001 | 943 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2015 | 267 | 0.030 |
Why?
|
| Tosyl Compounds | 1 | 2015 | 115 | 0.030 |
Why?
|
| Protein Structure, Secondary | 2 | 1995 | 1216 | 0.030 |
Why?
|
| Jaundice, Neonatal | 1 | 1995 | 70 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2019 | 1866 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2001 | 1780 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2021 | 1406 | 0.030 |
Why?
|
| Gadolinium | 1 | 2019 | 965 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 2631 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2019 | 1019 | 0.030 |
Why?
|
| Oxygen | 2 | 2018 | 4272 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3810 | 0.030 |
Why?
|
| Freeze Fracturing | 1 | 1994 | 70 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1731 | 0.030 |
Why?
|
| Lactones | 1 | 2016 | 316 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2002 | 1248 | 0.030 |
Why?
|
| Massachusetts | 2 | 2020 | 8894 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2001 | 1309 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 2015 | 386 | 0.030 |
Why?
|
| Body Mass Index | 3 | 2024 | 13055 | 0.030 |
Why?
|
| Obesity | 3 | 2024 | 13091 | 0.030 |
Why?
|
| Solubility | 2 | 2007 | 1087 | 0.030 |
Why?
|
| Brachial Artery | 1 | 2015 | 373 | 0.030 |
Why?
|
| Leuprolide | 1 | 2015 | 313 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2022 | 2452 | 0.030 |
Why?
|
| COS Cells | 1 | 2015 | 1135 | 0.030 |
Why?
|
| Anemia, Hemolytic, Congenital | 1 | 1993 | 71 | 0.030 |
Why?
|
| Galectins | 1 | 2016 | 295 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 2002 | 1065 | 0.030 |
Why?
|
| Child | 6 | 2024 | 80960 | 0.030 |
Why?
|
| Tunica Intima | 1 | 2015 | 459 | 0.030 |
Why?
|
| Sodium Channel Blockers | 1 | 2014 | 173 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 2009 | 0.030 |
Why?
|
| Incidence | 3 | 2019 | 21547 | 0.030 |
Why?
|
| Pyrroles | 2 | 2011 | 1125 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1994 | 781 | 0.030 |
Why?
|
| Forensic Toxicology | 1 | 2012 | 5 | 0.030 |
Why?
|
| Urine | 1 | 2014 | 362 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 1998 | 2342 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2010 | 12174 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2019 | 2635 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2020 | 841 | 0.030 |
Why?
|
| Hematocrit | 1 | 1994 | 623 | 0.030 |
Why?
|
| Prevalence | 2 | 2021 | 15879 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 11230 | 0.020 |
Why?
|
| Carcinoma, Papillary | 1 | 2017 | 793 | 0.020 |
Why?
|
| Anilides | 1 | 2015 | 414 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1996 | 905 | 0.020 |
Why?
|
| Adolescent | 6 | 2024 | 89244 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2006 | 5110 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2024 | 42683 | 0.020 |
Why?
|
| Gene Library | 1 | 1994 | 1062 | 0.020 |
Why?
|
| Bilirubin | 1 | 1994 | 438 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 2017 | 914 | 0.020 |
Why?
|
| Protein Binding | 2 | 2015 | 9344 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 1112 | 0.020 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2011 | 29 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 7460 | 0.020 |
Why?
|
| Creatinine | 1 | 2017 | 1917 | 0.020 |
Why?
|
| Dyspnea | 1 | 2019 | 1352 | 0.020 |
Why?
|
| Hemin | 1 | 1990 | 51 | 0.020 |
Why?
|
| Eosinophilia | 1 | 2015 | 556 | 0.020 |
Why?
|
| Chemokines | 1 | 2015 | 963 | 0.020 |
Why?
|
| Alanine | 1 | 1993 | 614 | 0.020 |
Why?
|
| Cause of Death | 2 | 2012 | 3721 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 1945 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2016 | 1042 | 0.020 |
Why?
|
| Age Factors | 2 | 2018 | 18435 | 0.020 |
Why?
|
| Pregnancy | 4 | 2012 | 30265 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2016 | 1560 | 0.020 |
Why?
|
| Epitopes | 1 | 1997 | 2529 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 2749 | 0.020 |
Why?
|
| Disease Management | 1 | 2021 | 2537 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2011 | 250 | 0.020 |
Why?
|
| Longitudinal Studies | 3 | 2018 | 14794 | 0.020 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2019 | 1077 | 0.020 |
Why?
|
| Prenylation | 1 | 2010 | 37 | 0.020 |
Why?
|
| Acyl Coenzyme A | 1 | 2010 | 56 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2016 | 1079 | 0.020 |
Why?
|
| Neutrophils | 1 | 2023 | 3785 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2004 | 2974 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2016 | 9684 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 1998 | 1894 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2748 | 0.020 |
Why?
|
| Monitoring, Ambulatory | 1 | 2013 | 358 | 0.020 |
Why?
|
| Glycine | 1 | 1993 | 672 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 2211 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2016 | 1530 | 0.020 |
Why?
|
| Cardiac Myosins | 1 | 2010 | 128 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 1092 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3813 | 0.020 |
Why?
|
| Nitriles | 1 | 2015 | 990 | 0.020 |
Why?
|
| Abortion, Spontaneous | 1 | 1994 | 535 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 1461 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2019 | 2936 | 0.020 |
Why?
|
| Angina, Unstable | 1 | 2013 | 893 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 1995 | 1191 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1996 | 3956 | 0.020 |
Why?
|
| Biological Evolution | 1 | 1994 | 1077 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 13021 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2010 | 404 | 0.020 |
Why?
|
| Hematinics | 1 | 2011 | 282 | 0.020 |
Why?
|
| Vaccination | 1 | 2021 | 3438 | 0.020 |
Why?
|
| Assisted Circulation | 1 | 2008 | 100 | 0.020 |
Why?
|
| Cardiovascular Agents | 1 | 2014 | 849 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2003 | 3447 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2018 | 1924 | 0.020 |
Why?
|
| Automation | 1 | 2011 | 589 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 6512 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1992 | 1885 | 0.020 |
Why?
|
| Rest | 1 | 2013 | 951 | 0.020 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 1989 | 131 | 0.020 |
Why?
|
| Triglycerides | 1 | 2015 | 2464 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6805 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1995 | 1423 | 0.020 |
Why?
|
| Apoptosis | 2 | 2016 | 9527 | 0.020 |
Why?
|
| Syndrome | 2 | 2006 | 3274 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1990 | 1647 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2007 | 159 | 0.020 |
Why?
|
| Research Design | 2 | 2017 | 6214 | 0.020 |
Why?
|
| DNA Repair | 1 | 2016 | 2054 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 6856 | 0.020 |
Why?
|
| Death | 1 | 2011 | 683 | 0.020 |
Why?
|
| Erythropoietin | 1 | 2011 | 718 | 0.020 |
Why?
|
| United States | 3 | 2019 | 73186 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2016 | 23653 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 2472 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1994 | 4625 | 0.020 |
Why?
|
| Contrast Media | 1 | 2019 | 5334 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 1990 | 498 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 2431 | 0.020 |
Why?
|
| Ventricular Pressure | 1 | 2007 | 210 | 0.020 |
Why?
|
| Infant | 2 | 2021 | 36556 | 0.020 |
Why?
|
| Fucosyltransferases | 1 | 2006 | 118 | 0.020 |
Why?
|
| Receptors, CXCR3 | 1 | 2006 | 240 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 36854 | 0.020 |
Why?
|
| Cardiotonic Agents | 1 | 2008 | 544 | 0.020 |
Why?
|
| Internationality | 1 | 2011 | 1008 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 3238 | 0.020 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2010 | 856 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8664 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1990 | 2226 | 0.010 |
Why?
|
| Boston | 1 | 2017 | 9377 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2014 | 6346 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2011 | 1408 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 2600 | 0.010 |
Why?
|
| Retroviridae | 1 | 2006 | 849 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 4207 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1989 | 3057 | 0.010 |
Why?
|
| Adiposity | 1 | 2014 | 1895 | 0.010 |
Why?
|
| Logistic Models | 2 | 2010 | 13318 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 1328 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 824 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6236 | 0.010 |
Why?
|
| Genome, Human | 1 | 1996 | 4456 | 0.010 |
Why?
|
| Swine | 1 | 2013 | 5997 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1994 | 5801 | 0.010 |
Why?
|
| Actins | 1 | 1990 | 2065 | 0.010 |
Why?
|
| Fibrosis | 1 | 2010 | 2080 | 0.010 |
Why?
|
| Ventricular Function, Right | 1 | 2007 | 628 | 0.010 |
Why?
|
| Genital Neoplasms, Female | 1 | 2007 | 538 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 2003 | 611 | 0.010 |
Why?
|
| Pediatrics | 1 | 2017 | 3628 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 1 | 2004 | 458 | 0.010 |
Why?
|
| Receptors, Endothelin | 1 | 2002 | 56 | 0.010 |
Why?
|
| Collagen | 1 | 2010 | 2646 | 0.010 |
Why?
|
| Quality Control | 1 | 2005 | 836 | 0.010 |
Why?
|
| Receptor, Endothelin B | 1 | 2002 | 46 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2014 | 3335 | 0.010 |
Why?
|
| Spain | 1 | 2003 | 485 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2008 | 1481 | 0.010 |
Why?
|
| Platelet Activating Factor | 1 | 2002 | 143 | 0.010 |
Why?
|
| Rubidium Radioisotopes | 1 | 2002 | 97 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 2002 | 157 | 0.010 |
Why?
|
| Data Collection | 1 | 2011 | 3324 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 2483 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1995 | 7609 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2002 | 283 | 0.010 |
Why?
|
| Thyrotropin | 1 | 2004 | 834 | 0.010 |
Why?
|
| Linear Models | 1 | 2011 | 5891 | 0.010 |
Why?
|
| Software | 1 | 1995 | 4479 | 0.010 |
Why?
|
| Ventricular Fibrillation | 1 | 2003 | 537 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11684 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 3713 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4879 | 0.010 |
Why?
|
| Cell Size | 1 | 2002 | 626 | 0.010 |
Why?
|
| Receptors, CCR5 | 1 | 2002 | 491 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2011 | 3473 | 0.010 |
Why?
|
| Ligands | 1 | 2006 | 3283 | 0.010 |
Why?
|
| Opioid-Related Disorders | 1 | 2014 | 2188 | 0.010 |
Why?
|
| Cell Communication | 1 | 2006 | 1660 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2001 | 699 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 1056 | 0.010 |
Why?
|
| Neoplasms | 1 | 2007 | 22389 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 859 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 2231 | 0.010 |
Why?
|
| Homozygote | 2 | 1994 | 1780 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2007 | 2403 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 2007 | 1483 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2010 | 3592 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2002 | 1207 | 0.010 |
Why?
|
| Estradiol | 1 | 2004 | 1952 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 3709 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 4862 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2002 | 1183 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2002 | 1194 | 0.010 |
Why?
|
| RNA, Complementary | 1 | 1995 | 46 | 0.010 |
Why?
|
| Microsomes | 1 | 1995 | 252 | 0.010 |
Why?
|
| Biopolymers | 1 | 1995 | 183 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1995 | 388 | 0.010 |
Why?
|
| Length of Stay | 1 | 2008 | 6526 | 0.010 |
Why?
|
| Xenopus | 1 | 1995 | 711 | 0.010 |
Why?
|
| Hospitals | 1 | 2007 | 3904 | 0.010 |
Why?
|
| Heart | 1 | 2006 | 4447 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2003 | 1515 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1995 | 662 | 0.010 |
Why?
|
| Skin | 1 | 2006 | 4506 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 8144 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1993 | 1435 | 0.010 |
Why?
|
| Biological Transport | 1 | 1995 | 2085 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1993 | 461 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2001 | 4179 | 0.010 |
Why?
|
| Oocytes | 1 | 1995 | 1172 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2004 | 3591 | 0.010 |
Why?
|
| Calcium | 1 | 2002 | 5792 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 2094 | 0.000 |
Why?
|
| Colorectal Neoplasms | 1 | 2007 | 6982 | 0.000 |
Why?
|
| Rats | 1 | 2003 | 23786 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 9618 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 21188 | 0.000 |
Why?
|